Reimbursement and Coding for Biosimilars: How Billing Works Under Medicare Part B
17
Feb
Medications
Peyton Holyfield
Biosimilars are billed differently than generics under Medicare Part B. Learn how HCPCS codes, the 106% reimbursement rule, and the JZ modifier affect provider payments and why adoption remains low despite lower costs.
ReadMore